Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Nature medicine - 1 Apr 2004

Passage Edith, Norreel Jean Chrétien, Noack-Fraissignes Pauline, Sanguedolce Véronique, Pizant Josette, Thirion Xavier, Robaglia-Schlupp Andrée, Pellissier Jean François, Fontés Michel

Abstract excerpt

Charcot-Marie-Tooth disease (CMT) is the most common hereditary peripheral neuropathy, affecting 1 in 2,500 people. The only treatment currently available is rehabilitation or corrective surgery. The most frequent form of the disease, CMT-1A, involves abnormal myelination of the peripheral nerves...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascorbic Acid
Share to Base Sequence
Share to Charcot-Marie-Tooth Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Primers

Share to Gene Expression Regulation

Share to Myelin Proteins

Share to Sciatic Nerve

Source

Identifiers

PMID: 15034573
DOI: 10.1038/nm1023

Genes

PMP22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15034573-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.PMID 15034573Read ↗

Diagnosis, natural history, and management of Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.Semantic proximity Read ↗

Recent advances in Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease.Semantic proximity Read ↗

The Current State of Charcot–Marie–Tooth Disease TreatmentSemantic proximity Read ↗

Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.Semantic proximity Read ↗

The Current State of Charcot-Marie-Tooth Disease Treatment.Semantic proximity Read ↗

Treatment of Charcot-Marie-Tooth neuropathies.Semantic proximity Read ↗

Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A.Semantic proximity Read ↗

Animal models of inherited neuropathiesSemantic proximity Read ↗

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.Semantic proximity Read ↗

Natural history and treatment of peripheral inherited neuropathies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.